Finance

Beta
Lists
MTNB:NYSEAMERICAN
Matinas BioPharma Holdings Inc
$0.81
+1.95%
(+0.016) 1D
May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MTNB...
Open
$0.75
High
$0.83
Low
$0.72
Mkt. cap
5.22M
Avg. vol.
257.06K
Volume
40.39K
52-wk high
$3.09
52-wk low
$0.48
EPS
-$1.92
Beta
1.67
Shares outstanding
6.41M
No. of employees
2
Open
$0.75
High
$0.83
Low
$0.72
Mkt. cap
5.22M
Avg. vol.
257.06K
Volume
40.39K
52-wk high
$3.09
52-wk low
$0.48
EPS
-$1.92
Beta
1.67
Shares outstanding
6.41M
No. of employees
2
News stories
From sources across the web
About Matinas BioPharma Holdings Inc
CEO-
Employees2
Founded2013
HeadquartersBedminster, New Jersey, United States
SectorBiotechnology
Websitematinasbiopharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.84M
1.58M
1.60M
1.94M
Operating expense
1.84M
1.58M
1.60M
1.94M
Total operating expenses
1.84M
1.58M
1.60M
1.94M
Operating income
-1.84M
-1.58M
-1.60M
-1.94M
Other non operating income
-63.00K
45.00K
-238.00K
15.00K
EBT including unusual items
-5.24M
-1.53M
-1.91M
-1.92M
EBT excluding unusual items
-1.90M
-1.53M
-1.84M
-1.92M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.24M
-1.53M
-1.91M
-1.92M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-1.00K
-
Net interest expenses
-
-
-1.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.82M
-1.58M
-1.60M
-1.93M
Gain or loss from assets sale
-110.00K
-
73.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer